Skip to content
XPR – Lifestyle Demo
Author:
EpiFrontier Therapeutics
EpiFrontier Therapeutics Secures up to $32M Grant from the Japan Agency for Medical Research and Development to Advance Novel Therapy for Beta Globin Disorders
March 24, 2026